Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Sanofi
 More »

  • Vical Scraps Melanoma Candidate After Phase III Failure
    ... Two of Vical's products have been licensed for animal indications by other companies: In 2009 before its acquisition by Sanofi, Merial won approval from the U.S. Department of ...
    8-12-2013
  • Double Manufacturing Deals for Sanofi
    Two Sanofi companies have entered biomanufacturing deals with Vivus and Gallus Biopharmaceuticals. Sanofi subsidiary Sanofi Chimie has made an agreement with Vivus to manufacture ...
    8-1-2013
  • High School Whiz Kids Win Scientific Prestige . . . and Big Bucks
    ... a Sanofi BioGENEius Challenge Canada prize for his cancer research. Arjun Nair, 16, who is an 11th grader at Webber Academy in Calgary, Alberta, Canada, took home the top Sanofi ...
    8-1-2013
  • What the Top 15 Biopharma CEOs Are Making
    As a result, this year the CEOs from Roche and Sanofi joined Novartis in raising the ... #15. Christopher Viehbacher Company: Sanofi Full title: CEO 2012 Compensation: ...
    7-31-2013
  • EFPIA, PhRMA: Trial Data-Sharing Benefits Patients, Scientists...
    being put forth in the European Union." Added EFPIA President and member company Sanofi CEO Christopher Viehbacher: "By endorsing the Principles, biopharmaceutical companies ...
    7-25-2013
  • Top 15 Pharma Companies of 2013
    pharmas climbed up the list (Novartis and Sanofi); four slipped a notch or more (Roche, ... 19.6% Position on 2012 List: #4 #5. Sanofi 2013 Market Cap: $148.381 billion (5/10: ...
    7-19-2013
  • Across Pharma, Few Open Arms for Trial Data Sharing
    drugs since 2010. At the other end, Sanofi CEO Christopher A. Viehbacher has drawn ... news outlets in June. Speaking as Sanofi CEO, he added: "If I was to say where ...
    7-8-2013
  • Top 15 Vaccines of 2012
    Merck & Co. and Sanofi account for more than half of the vaccines on the list, both individually and collectively; the two companies maintain a joint venture, Sanofi Pasteur MSD, ...
    7-2-2013
  • Top 10 Pharma Giants Now Hiring
    ... (18); Taiwan (17); Ukraine (16) Next five countries % of available jobs: 40.0% #3. Sanofi 4 1,427 total worldwide jobs listed on website 4 Top nation: U.S., with 744 jobs ...
    6-27-2013
  • Pharma Touts Phase III Wins for Type 2 Diabetes Drugs at ADA...
    Boehringer Ingelheim (BI), Eli Lilly, and Sanofi were among those firms that presented ... Sanofi, too, presented promising Phase III results at the American Diabetes Association ...
    6-24-2013
  • Sanofi, Curie-Cancer Partner on Ovarian Cancer Drug Discovery...
    Sanofi and the Curie Institute are teaming up as part of a three-year preclinical research ... Participating through its Institut Carnot arm, Curie-Cancer is working with Sanofi to ...
    6-20-2013
  • NCATS Awards $12.7M for Nine Drug Repurposing Projects
    One of those comes from Sanofi, while the other is among a pair of AstraZeneca compounds ... on an undisclosed Sanofi compound against Duchenne muscular dystrophy (DMD). ...
    6-18-2013
  • Cancer's Bitter Medicine
    ... When physicians raised the issue in The New York Times, Zaltrap developer Sanofi began offering 50% discounts while maintaining the official price. Joshua P. Cohen, senior research ...
    6-15-2013
  • Macrocycles Shake Up Small Molecules
    ... Hoflack said. Working in collaboration with pharma teams such as Ipsen and Sanofi, Oncodesign is currently developing inhibitory compounds of the leucine-rich repeat kinase 2 ...
    6-15-2013
  • Top 20 Corporate Venture Funds
    ... 2001; name changed in 2011 #11. (tie) Sanofi-Genzyme BioVentures (formerly Genzyme ... promise to deliver breakthrough products that may be future Sanofi pipeline candidates. ...
    6-14-2013
  • More »

    Journal Articles

  • Performance of a New Reusable Insulin Pen
    Alfred Penfornis
    Diabetes Technology & Therapeutics
    ease of use and performance of the ClikSTAR® (sanofi-aventis, Paris, France) insulin pen with other commonly used reusable pens based on participant and interviewer assessments. ...
  • Initiating Insulin Therapy in Type 2 Diabetes: Benefits of Insulin...
    Stephen Brunton
    Diabetes Technology & Therapeutics
    series, Novo Nordisk [Bagsvaerd, Denmark]) or disposable (prefilled; e.g., FlexPen®, Novo Nordisk; SoloSTAR®, sanofi-aventis [Paris, France]), with features to aid ease-of-use. ...
  • Dosing of Insulin Glargine to Achieve the Treatment Target in...
    Masato Odawara, Tetsuya Ohtani, Takashi Kadowaki
    Diabetes Technology & Therapeutics
    Abstract Aim/Introduction: Subsample analysis was performed to examine whether dose optimization of insulin glargine (Lantus®; sanofi-aventis K.K., Tokyo, Japan) contributed to ...
  • An Ultraviolet-Spectrophotometric Method for the Determination...
    Ozadheoghene E. Afieroho, Ogbonna Okorie, Tochukwu J.N. Okonkwo
    Diabetes Technology & Therapeutics
    with comparable reproducibility when used to assay the formulated products Amaryl® (sanofi-aventis, Paris, France) and Mepyril® (May & Baker Nigeria PLC, Ikeja, Nigeria). The ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll